Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified
Wunan Zhou1, Meron Teklu1, Vy Bui1
1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Insights
Systemic inflammation and early coronary artery disease (noncalcified coronary burden) both contribute to increased left ventricular mass in psoriasis patients. Noncalcified coronary burden partially mediates the link between inflammation and left ventricular mass.
Area of Science:
- Cardiology
- Inflammation Research
- Dermatology
Background:
- Increased left ventricular (LV) mass is a significant precursor to heart failure.
- Systemic inflammation plays a key role in the development of LV mass.
- The specific contribution of subclinical coronary artery disease (CAD) to this inflammation-LV mass relationship remains unclear.
Purpose of the Study:
- To investigate the association between systemic inflammation, measured by plasma glycoprotein A (GlycA), and LV mass in psoriasis patients.
- To determine if early CAD, assessed as noncalcified coronary burden (NCB), mediates the relationship between GlycA and LV mass.
- To evaluate the longitudinal association between changes in NCB and changes in LV mass.
Main Methods:
- An observational longitudinal study involving 213 subjects with psoriasis and no known cardiovascular disease.
- Measurements included plasma GlycA (nuclear magnetic resonance spectroscopy) and LV mass and NCB (coronary CT angiography).
- 189 participants were followed for one year, with repeated measurements of LV mass and NCB.
Main Results:
- LV mass significantly increased across tertiles of GlycA (p<0.001).
- Both GlycA (β=0.24, p=0.001) and NCB (β=0.50, p<0.001) were independently associated with LV mass after adjusting for multiple risk factors.
- Mediation analysis revealed that NCB accounted for 32% of the GlycA-LV mass association. Longitudinal analysis showed change in NCB independently predicted change in LV mass (β=0.25, p=0.002).
Conclusions:
- Both systemic inflammation (GlycA) and coronary artery NCB are associated with LV mass in psoriasis patients, independent of traditional cardiovascular risk factors.
- NCB significantly mediates the relationship between systemic inflammation and LV mass.
- These findings highlight the potential role of early coronary atherosclerosis in linking systemic inflammation to LV mass.
Objective:
Increased left ventricular (LV) mass is an important precursor to heart failure. Inflammation plays an important role in increasing LV mass. However, the contribution of subclinical coronary artery disease (CAD) to the inflammation-LV mass relationship is unknown. In subjects with psoriasis, a chronic inflammatory skin disease, we evaluated if systemic inflammation assessed by plasma glycoprotein A (GlycA) associated with LV mass measured on coronary CT angiography (CCTA). Additionally, we analyzed whether this relationship was mediated by early CAD assessed as noncalcified coronary burden (NCB).
Methods:
We performed an observational longitudinal study of 213 subjects with psoriasis free of known cardiovascular disease, 189 of whom were followed over one year. All participants had GlycA measurements by nuclear magnetic resonance spectroscopy and LV mass and NCB quantified by CCTA.
Results:
The cohort had a mean age of 50.3 (±12.9) years and 59% were male. There was moderate psoriasis severity and low cardiovascular risk. LV mass increased by GlycA tertiles [1st tertile:24.6 g/m2.7(3.8), 2nd tertile:25.5 g/m2.7(3.8), 3rd tertile:27.7 g/m2.7(5.5), p<0.001]. Both GlycA (β=0.24, p = 0.001) and NCB (β=0.50, p<0.001) associated with LV mass in models adjusted for age, sex, hypertension, hypertension therapy, lipid therapy, biologic therapy for psoriasis, waist:hip ratio, psoriasis disease duration and severity. In multivariable-adjusted mediation analyses, NCB accounted for 32% of the GlycA-LV mass relationship. Finally, over one year, change in NCB independently associated with change in LV mass (β=0.25, p = 0.002).
Conclusions:
Both systemic inflammation and coronary artery NCB were associated with LV mass beyond cardiovascular risk factors in psoriasis. Furthermore, a substantial proportion of the inflammatory-LV mass relationship was mediated by NCB. These findings underscore the possible contribution of early coronary artery disease to the relationship between systemic inflammation and LV mass.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction